Global and United States Point-of-Care Infectious Disease Diagnostics/Testing Market 2020 by Company, Type and Application, Forecast to 2025

Publisher Name :
Date: 29-Feb-2020
No. of pages: 130

Market Overview

The global Point-of-Care Infectious Disease Diagnostics/Testing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.2% in the forecast period of 2020 to 2025 and will expected to reach USD 1257.8 million by 2025, from USD 1026.6 million in 2019.

The Point-of-Care Infectious Disease Diagnostics/Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation

Point-of-Care Infectious Disease Diagnostics/Testing market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for revenue by Type and Application. This analysis can help you expand your business by targeting qualified niche markets.

Breakdown by Type, Point-of-Care Infectious Disease Diagnostics/Testing market has been segmented into HIV POC, Clostridium difficile POC, HBV POC, Pneumonia or Streptococcus associated infections, Respiratory syncytial virus (RSV) POC, HPV POC, Influenza/Flu POC, Other Infectious Disease POC, etc.

Breakdown by Application, Point-of-Care Infectious Disease Diagnostics/Testing has been segmented into Hospitals, Clinics, Home, Assisted Living Healthcare Facilities, Laboratories, Others, etc.

Regions and Countries Level Analysis

Regional analysis is another highly comprehensive part of the research and analysis study of the global Point-of-Care Infectious Disease Diagnostics/Testing market presented in the report. This section sheds light on the sales growth of different regional and country-level Point-of-Care Infectious Disease Diagnostics/Testing markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Point-of-Care Infectious Disease Diagnostics/Testing market.

For United States, this report analyses the United States market by players, Type and Application, for the period 2015-2025.

Competitive Landscape and Point-of-Care Infectious Disease Diagnostics/Testing Market Share Analysis

Point-of-Care Infectious Disease Diagnostics/Testing competitive landscape provides details by vendors, including company overview, company total revenue, market potential, global presence, Point-of-Care Infectious Disease Diagnostics/Testing revenue generated, market share, headquarters, SWOT analysis, product launch. For the period 2015-2020, this study provides the Point-of-Care Infectious Disease Diagnostics/Testing revenue and market share for each player covered in this report.

The major players covered in Point-of-Care Infectious Disease Diagnostics/Testing are: Abbott, Cardinal Health, Siemens Healthineers, Thermo Fisher Scientific Inc, Trinity Biotech, F. Hoffmann-La Roche Ltd, Bio-Rad Labs Inc., Chembio Diagnostics Inc., BD & Company, Quest Diagnostics Inc., OJ-Bio Ltd., bioMérieux SA, Ortho-Clinical Diagnostics, Trivitron Healthcare, Sight Diagnostics Ltd., Gene POC, etc. Among other players domestic and global, Point-of-Care Infectious Disease Diagnostics/Testing market share data is available for global, North America, Europe, Asia, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Market segment by players, this report covers

- Abbott

- Cardinal Health

- Siemens Healthineers

- Thermo Fisher Scientific Inc

- Trinity Biotech

- F. Hoffmann-La Roche Ltd

- Bio-Rad Labs Inc.

- Chembio Diagnostics Inc.

- BD & Company

- Quest Diagnostics Inc.

- OJ-Bio Ltd.

- bioMérieux SA

- Ortho-Clinical Diagnostics

- Trivitron Healthcare

- Sight Diagnostics Ltd.

- Gene POC

Market segment by regions, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, UK, Russia and Italy)

- Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)

- South America (Brazil, Argentina)

- MENA (Saudi Arabia, UAE, Turkey and South Africa)

Market segment by Type, covers:

- HIV POC

- Clostridium difficile POC

- HBV POC

- Pneumonia or Streptococcus associated infections

- Respiratory syncytial virus (RSV) POC

- HPV POC

- Influenza/Flu POC

- Other Infectious Disease POC

Market segment by Application, can be divided into

- Hospitals

- Clinics

- Home

- Assisted Living Healthcare Facilities

- Laboratories

- Others

Global and United States Point-of-Care Infectious Disease Diagnostics/Testing Market 2020 by Company, Type and Application, Forecast to 2025

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Point-of-Care Infectious Disease Diagnostics/Testing
1.2 Classification of Point-of-Care Infectious Disease Diagnostics/Testing by Type
1.2.1 Overview: Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue by Type: 2015 Versus 2019 Versus 2025
1.2.2 Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue Market Share by Type in 2019
1.2.3 HIV POC
1.2.4 Clostridium difficile POC
1.2.5 HBV POC
1.2.6 Pneumonia or Streptococcus associated infections
1.2.7 Respiratory syncytial virus (RSV) POC
1.2.8 HPV POC
1.2.9 Influenza/Flu POC
1.2.10 Other Infectious Disease POC
1.3 Global Point-of-Care Infectious Disease Diagnostics/Testing Market by Application
1.3.1 Overview: Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue by Application: 2015 Versus 2019 Versus 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Home
1.3.5 Assisted Living Healthcare Facilities
1.3.6 Laboratories
1.3.7 Others
1.4 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size and Forecast (2015-2025)
1.5 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Regions: 2015 VS 2019 VS 2025
1.6 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Regions (2015-2020)
1.7 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size and Forecast by Regions (2020-2025)
1.7.1 North America Point-of-Care Infectious Disease Diagnostics/Testing Status and Prospect (2015-2025)
1.7.2 Europe Point-of-Care Infectious Disease Diagnostics/Testing Status and Prospect (2015-2025)
1.7.3 Asia Point-of-Care Infectious Disease Diagnostics/Testing Status and Prospect (2015-2025)
1.7.4 South America Point-of-Care Infectious Disease Diagnostics/Testing Status and Prospect (2015-2025)
1.7.5 Middle East & Africa Point-of-Care Infectious Disease Diagnostics/Testing Status and Prospect (2015-2025)

2 Company Profiles
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Abbott SWOT Analysis
2.1.4 Abbott Product and Services
2.1.5 Abbott Point-of-Care Infectious Disease Diagnostics/Testing Revenue, Gross Margin and Market Share (2018-2019)
2.2 Cardinal Health
2.2.1 Cardinal Health Details
2.2.2 Cardinal Health Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Cardinal Health SWOT Analysis
2.2.4 Cardinal Health Product and Services
2.2.5 Cardinal Health Point-of-Care Infectious Disease Diagnostics/Testing Revenue, Gross Margin and Market Share (2018-2019)
2.3 Siemens Healthineers
2.3.1 Siemens Healthineers Details
2.3.2 Siemens Healthineers Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Siemens Healthineers SWOT Analysis
2.3.4 Siemens Healthineers Product and Services
2.3.5 Siemens Healthineers Point-of-Care Infectious Disease Diagnostics/Testing Revenue, Gross Margin and Market Share (2018-2019)
2.4 Thermo Fisher Scientific Inc
2.4.1 Thermo Fisher Scientific Inc Details
2.4.2 Thermo Fisher Scientific Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Thermo Fisher Scientific Inc SWOT Analysis
2.4.4 Thermo Fisher Scientific Inc Product and Services
2.4.5 Thermo Fisher Scientific Inc Point-of-Care Infectious Disease Diagnostics/Testing Revenue, Gross Margin and Market Share (2018-2019)
2.5 Trinity Biotech
2.5.1 Trinity Biotech Details
2.5.2 Trinity Biotech Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Trinity Biotech SWOT Analysis
2.5.4 Trinity Biotech Product and Services
2.5.5 Trinity Biotech Point-of-Care Infectious Disease Diagnostics/Testing Revenue, Gross Margin and Market Share (2018-2019)
2.6 F. Hoffmann-La Roche Ltd
2.6.1 F. Hoffmann-La Roche Ltd Details
2.6.2 F. Hoffmann-La Roche Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 F. Hoffmann-La Roche Ltd SWOT Analysis
2.6.4 F. Hoffmann-La Roche Ltd Product and Services
2.6.5 F. Hoffmann-La Roche Ltd Point-of-Care Infectious Disease Diagnostics/Testing Revenue, Gross Margin and Market Share (2018-2019)
2.7 Bio-Rad Labs Inc.
2.7.1 Bio-Rad Labs Inc. Details
2.7.2 Bio-Rad Labs Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Bio-Rad Labs Inc. SWOT Analysis
2.7.4 Bio-Rad Labs Inc. Product and Services
2.7.5 Bio-Rad Labs Inc. Point-of-Care Infectious Disease Diagnostics/Testing Revenue, Gross Margin and Market Share (2018-2019)
2.8 Chembio Diagnostics Inc.
2.8.1 Chembio Diagnostics Inc. Details
2.8.2 Chembio Diagnostics Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Chembio Diagnostics Inc. SWOT Analysis
2.8.4 Chembio Diagnostics Inc. Product and Services
2.8.5 Chembio Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics/Testing Revenue, Gross Margin and Market Share (2018-2019)
2.9 BD & Company
2.9.1 BD & Company Details
2.9.2 BD & Company Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 BD & Company SWOT Analysis
2.9.4 BD & Company Product and Services
2.9.5 BD & Company Point-of-Care Infectious Disease Diagnostics/Testing Revenue, Gross Margin and Market Share (2018-2019)
2.10 Quest Diagnostics Inc.
2.10.1 Quest Diagnostics Inc. Details
2.10.2 Quest Diagnostics Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Quest Diagnostics Inc. SWOT Analysis
2.10.4 Quest Diagnostics Inc. Product and Services
2.10.5 Quest Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics/Testing Revenue, Gross Margin and Market Share (2018-2019)
2.11 OJ-Bio Ltd.
2.11.1 OJ-Bio Ltd. Details
2.11.2 OJ-Bio Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 OJ-Bio Ltd. SWOT Analysis
2.11.4 OJ-Bio Ltd. Product and Services
2.11.5 OJ-Bio Ltd. Point-of-Care Infectious Disease Diagnostics/Testing Revenue, Gross Margin and Market Share (2018-2019)
2.12 bioMérieux SA
2.12.1 bioMérieux SA Details
2.12.2 bioMérieux SA Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 bioMérieux SA SWOT Analysis
2.12.4 bioMérieux SA Product and Services
2.12.5 bioMérieux SA Point-of-Care Infectious Disease Diagnostics/Testing Revenue, Gross Margin and Market Share (2018-2019)
2.13 Ortho-Clinical Diagnostics
2.13.1 Ortho-Clinical Diagnostics Details
2.13.2 Ortho-Clinical Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Ortho-Clinical Diagnostics SWOT Analysis
2.13.4 Ortho-Clinical Diagnostics Product and Services
2.13.5 Ortho-Clinical Diagnostics Point-of-Care Infectious Disease Diagnostics/Testing Revenue, Gross Margin and Market Share (2018-2019)
2.14 Trivitron Healthcare
2.14.1 Trivitron Healthcare Details
2.14.2 Trivitron Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Trivitron Healthcare SWOT Analysis
2.14.4 Trivitron Healthcare Product and Services
2.14.5 Trivitron Healthcare Point-of-Care Infectious Disease Diagnostics/Testing Revenue, Gross Margin and Market Share (2018-2019)
2.15 Sight Diagnostics Ltd.
2.15.1 Sight Diagnostics Ltd. Details
2.15.2 Sight Diagnostics Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Sight Diagnostics Ltd. SWOT Analysis
2.15.4 Sight Diagnostics Ltd. Product and Services
2.15.5 Sight Diagnostics Ltd. Point-of-Care Infectious Disease Diagnostics/Testing Revenue, Gross Margin and Market Share (2018-2019)
2.16 Gene POC
2.16.1 Gene POC Details
2.16.2 Gene POC Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Gene POC SWOT Analysis
2.16.4 Gene POC Product and Services
2.16.5 Gene POC Point-of-Care Infectious Disease Diagnostics/Testing Revenue, Gross Margin and Market Share (2018-2019)

3 Market Competition, by Players
3.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Players (2015-2020)
3.2 United States Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Players (2015-2020)
3.3 Market Concentration Rate
3.3.1 Top 5 Point-of-Care Infectious Disease Diagnostics/Testing Players Market Share
3.3.2 Top 10 Point-of-Care Infectious Disease Diagnostics/Testing Players Market Share

4 North America Market Size and Forecast by Countries
4.1 North America Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Countries (2015-2020)
4.2 North America Point-of-Care Infectious Disease Diagnostics/Testing Market Size and Forecast by Countries (2015-2026)
4.3 United States Point-of-Care Infectious Disease Diagnostics/Testing Market Size and Forecast (2015-2025)
4.4 Canada Point-of-Care Infectious Disease Diagnostics/Testing Market Size and Forecast (2015-2025)
4.5 Mexico Point-of-Care Infectious Disease Diagnostics/Testing Market Size and Forecast (2015-2025)

5 Europe Market Size and Forecast by Countries
5.1 Europe Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Countries (2015-2020)
5.2 Europe Point-of-Care Infectious Disease Diagnostics/Testing Market Size and Forecast by Countries (2015-2026)
5.3 Germany Point-of-Care Infectious Disease Diagnostics/Testing Market Size and Forecast (2015-2025)
5.4 France Point-of-Care Infectious Disease Diagnostics/Testing Market Size and Forecast (2015-2025)
5.5 UK Point-of-Care Infectious Disease Diagnostics/Testing Market Size and Forecast (2015-2025)
5.6 Russia Point-of-Care Infectious Disease Diagnostics/Testing Market Size and Forecast (2015-2025)
5.7 Italy Point-of-Care Infectious Disease Diagnostics/Testing Market Size and Forecast (2015-2025)

6 Asia-Pacific Market Size and Forecast by Countries
6.1 Asia-Pacific Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Regions (2015-2020)
6.2 Asia-Pacific Point-of-Care Infectious Disease Diagnostics/Testing Market Size and Forecast by Regions (2015-2026)
6.3 China Point-of-Care Infectious Disease Diagnostics/Testing Market Size and Forecast (2015-2025)
6.4 Japan Point-of-Care Infectious Disease Diagnostics/Testing Market Size and Forecast (2015-2025)
6.5 Korea Point-of-Care Infectious Disease Diagnostics/Testing Market Size and Forecast (2015-2025)
6.6 India Point-of-Care Infectious Disease Diagnostics/Testing Market Size and Forecast (2015-2025)
6.7 Southeast Asia Point-of-Care Infectious Disease Diagnostics/Testing Market Size and Forecast (2015-2025)

7 South America Market Size and Forecast by Countries
7.1 South America Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Countries (2015-2020)
7.2 South America Point-of-Care Infectious Disease Diagnostics/Testing Market Size and Forecast by Countries (2015-2026)
7.3 Brazil Point-of-Care Infectious Disease Diagnostics/Testing Market Size and Forecast (2015-2025)
7.4 Argentina Point-of-Care Infectious Disease Diagnostics/Testing Market Size and Forecast (2015-2025)

8 Middle East & Africa Market Size and Forecast by Countries
8.1 Middle East & Africa Point-of-Care Infectious Disease Diagnostics/Testing Revenue by Regions (2015-2020)
8.2 Middle East & Africa Point-of-Care Infectious Disease Diagnostics/Testing Market Size and Forecast by Countries (2015-2026)
8.3 Saudi Arabia Point-of-Care Infectious Disease Diagnostics/Testing Market Size and Forecast (2015-2025)
8.4 UAE Point-of-Care Infectious Disease Diagnostics/Testing Market Size and Forecast (2015-2025)
8.5 Egypt Point-of-Care Infectious Disease Diagnostics/Testing Market Size and Forecast (2015-2025)
8.6 South Africa Point-of-Care Infectious Disease Diagnostics/Testing Market Size and Forecast (2015-2025)

9 Market Size Segment by Type
9.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size and Forecast by Type (2015-2025)
9.1.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Type (2015-2020)
9.1.2 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size Forecast by Type (2020-2025)
9.2 United States Point-of-Care Infectious Disease Diagnostics/Testing Market Size and Forecast by Type (2015-2025)
9.2.1 United States Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Type (2015-2020)
9.2.2 United States Point-of-Care Infectious Disease Diagnostics/Testing Market Size Forecast by Type (2020-2025)

10 Market Size Segment by Application
10.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size and Forecast by Application (2015-2025)
10.1.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Application (2015-2020)
10.1.2 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size Forecast by Application (2020-2025)
10.2 United States Point-of-Care Infectious Disease Diagnostics/Testing Market Size and Forecast by Application (2015-2025)
10.2.1 United States Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Application (2015-2020)
10.2.2 United States Point-of-Care Infectious Disease Diagnostics/Testing Market Size Forecast by Application (2020-2025)

11 Research Findings and Conclusion

12 Appendix
12.1 Methodology
12.2 Data Source
12.3 Disclaimer
12.4 About US

List of Tables

Table 1. Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue (USD Million) by Type: 2015 Versus 2019 Versus 2025
Table 2. Breakdown of Point-of-Care Infectious Disease Diagnostics/Testing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue (USD Million) by Application: 2015 Versus 2019 Versus 2025
Table 4. Global Market Point-of-Care Infectious Disease Diagnostics/Testing Market Size (USD Million) Comparison by Regions (2020-2025)
Table 5. Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue (USD Million) by Regions (2015-2020)
Table 6. Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue Share by Regions (2015-2020)
Table 7. Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue (USD Million) by Regions (2020-2025)
Table 8. Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue Market Share by Regions (2020-2025)
Table 9. Abbott Corporate Information, Location and Competitors
Table 10. Abbott Major Business
Table 11. Abbott Point-of-Care Infectious Disease Diagnostics/Testing Total Revenue (USD Million) (2017-2018)
Table 12. Abbott SWOT Analysis
Table 13. Abbott Point-of-Care Infectious Disease Diagnostics/Testing Product and Solutions
Table 14. Abbott Point-of-Care Infectious Disease Diagnostics/Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 15. Cardinal Health Corporate Information, Location and Competitors
Table 16. Cardinal Health Major Business
Table 17. Cardinal Health Point-of-Care Infectious Disease Diagnostics/Testing Total Revenue (USD Million) (2018-2019)
Table 18. Cardinal Health SWOT Analysis
Table 19. Cardinal Health Point-of-Care Infectious Disease Diagnostics/Testing Product and Solutions
Table 20. Cardinal Health Point-of-Care Infectious Disease Diagnostics/Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 21. Siemens Healthineers Corporate Information, Location and Competitors
Table 22. Siemens Healthineers Major Business
Table 23. Siemens Healthineers Point-of-Care Infectious Disease Diagnostics/Testing Total Revenue (USD Million) (2017-2018)
Table 24. Siemens Healthineers SWOT Analysis
Table 25. Siemens Healthineers Point-of-Care Infectious Disease Diagnostics/Testing Product and Solutions
Table 26. Siemens Healthineers Point-of-Care Infectious Disease Diagnostics/Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 27. Thermo Fisher Scientific Inc Corporate Information, Location and Competitors
Table 28. Thermo Fisher Scientific Inc Major Business
Table 29. Thermo Fisher Scientific Inc Point-of-Care Infectious Disease Diagnostics/Testing Total Revenue (USD Million) (2017-2018)
Table 30. Thermo Fisher Scientific Inc SWOT Analysis
Table 31. Thermo Fisher Scientific Inc Point-of-Care Infectious Disease Diagnostics/Testing Product and Solutions
Table 32. Thermo Fisher Scientific Inc Point-of-Care Infectious Disease Diagnostics/Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 33. Trinity Biotech Corporate Information, Location and Competitors
Table 34. Trinity Biotech Major Business
Table 35. Trinity Biotech Point-of-Care Infectious Disease Diagnostics/Testing Total Revenue (USD Million) (2017-2018)
Table 36. Trinity Biotech SWOT Analysis
Table 37. Trinity Biotech Point-of-Care Infectious Disease Diagnostics/Testing Product and Solutions
Table 38. Trinity Biotech Point-of-Care Infectious Disease Diagnostics/Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 39. F. Hoffmann-La Roche Ltd Corporate Information, Location and Competitors
Table 40. F. Hoffmann-La Roche Ltd Major Business
Table 41. F. Hoffmann-La Roche Ltd Point-of-Care Infectious Disease Diagnostics/Testing Total Revenue (USD Million) (2017-2018)
Table 42. F. Hoffmann-La Roche Ltd SWOT Analysis
Table 43. F. Hoffmann-La Roche Ltd Point-of-Care Infectious Disease Diagnostics/Testing Product and Solutions
Table 44. F. Hoffmann-La Roche Ltd Point-of-Care Infectious Disease Diagnostics/Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 45. Bio-Rad Labs Inc. Corporate Information, Location and Competitors
Table 46. Bio-Rad Labs Inc. Major Business
Table 47. Bio-Rad Labs Inc. Point-of-Care Infectious Disease Diagnostics/Testing Total Revenue (USD Million) (2017-2018)
Table 48. Bio-Rad Labs Inc. SWOT Analysis
Table 49. Bio-Rad Labs Inc. Point-of-Care Infectious Disease Diagnostics/Testing Product and Solutions
Table 50. Bio-Rad Labs Inc. Point-of-Care Infectious Disease Diagnostics/Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 51. Chembio Diagnostics Inc. Corporate Information, Location and Competitors
Table 52. Chembio Diagnostics Inc. Major Business
Table 53. Chembio Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics/Testing Total Revenue (USD Million) (2017-2018)
Table 54. Chembio Diagnostics Inc. SWOT Analysis
Table 55. Chembio Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics/Testing Product and Solutions
Table 56. Chembio Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics/Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 57. BD & Company Corporate Information, Location and Competitors
Table 58. BD & Company Major Business
Table 59. BD & Company Point-of-Care Infectious Disease Diagnostics/Testing Total Revenue (USD Million) (2017-2018)
Table 60. BD & Company SWOT Analysis
Table 61. BD & Company Point-of-Care Infectious Disease Diagnostics/Testing Product and Solutions
Table 62. BD & Company Point-of-Care Infectious Disease Diagnostics/Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 63. Quest Diagnostics Inc. Corporate Information, Location and Competitors
Table 64. Quest Diagnostics Inc. Major Business
Table 65. Quest Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics/Testing Total Revenue (USD Million) (2017-2018)
Table 66. Quest Diagnostics Inc. SWOT Analysis
Table 67. Quest Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics/Testing Product and Solutions
Table 68. Quest Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics/Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 69. OJ-Bio Ltd. Corporate Information, Location and Competitors
Table 70. OJ-Bio Ltd. Major Business
Table 71. OJ-Bio Ltd. Point-of-Care Infectious Disease Diagnostics/Testing Total Revenue (USD Million) (2017-2018)
Table 72. OJ-Bio Ltd. SWOT Analysis
Table 73. OJ-Bio Ltd. Point-of-Care Infectious Disease Diagnostics/Testing Product and Solutions
Table 74. OJ-Bio Ltd. Point-of-Care Infectious Disease Diagnostics/Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 75. bioMérieux SA Corporate Information, Location and Competitors
Table 76. bioMérieux SA Major Business
Table 77. bioMérieux SA Point-of-Care Infectious Disease Diagnostics/Testing Total Revenue (USD Million) (2017-2018)
Table 78. bioMérieux SA SWOT Analysis
Table 79. bioMérieux SA Point-of-Care Infectious Disease Diagnostics/Testing Product and Solutions
Table 80. bioMérieux SA Point-of-Care Infectious Disease Diagnostics/Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 81. Ortho-Clinical Diagnostics Corporate Information, Location and Competitors
Table 82. Ortho-Clinical Diagnostics Major Business
Table 83. Ortho-Clinical Diagnostics Point-of-Care Infectious Disease Diagnostics/Testing Total Revenue (USD Million) (2017-2018)
Table 84. Ortho-Clinical Diagnostics SWOT Analysis
Table 85. Ortho-Clinical Diagnostics Point-of-Care Infectious Disease Diagnostics/Testing Product and Solutions
Table 86. Ortho-Clinical Diagnostics Point-of-Care Infectious Disease Diagnostics/Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 87. Trivitron Healthcare Corporate Information, Location and Competitors
Table 88. Trivitron Healthcare Major Business
Table 89. Trivitron Healthcare Point-of-Care Infectious Disease Diagnostics/Testing Total Revenue (USD Million) (2017-2018)
Table 90. Trivitron Healthcare SWOT Analysis
Table 91. Trivitron Healthcare Point-of-Care Infectious Disease Diagnostics/Testing Product and Solutions
Table 92. Trivitron Healthcare Point-of-Care Infectious Disease Diagnostics/Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 93. Sight Diagnostics Ltd. Corporate Information, Location and Competitors
Table 94. Sight Diagnostics Ltd. Major Business
Table 95. Sight Diagnostics Ltd. Point-of-Care Infectious Disease Diagnostics/Testing Total Revenue (USD Million) (2017-2018)
Table 96. Sight Diagnostics Ltd. SWOT Analysis
Table 97. Sight Diagnostics Ltd. Point-of-Care Infectious Disease Diagnostics/Testing Product and Solutions
Table 98. Sight Diagnostics Ltd. Point-of-Care Infectious Disease Diagnostics/Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 99. Gene POC Corporate Information, Location and Competitors
Table 100. Gene POC Major Business
Table 101. Gene POC Point-of-Care Infectious Disease Diagnostics/Testing Total Revenue (USD Million) (2017-2018)
Table 102. Gene POC SWOT Analysis
Table 103. Gene POC Point-of-Care Infectious Disease Diagnostics/Testing Product and Solutions
Table 104. Gene POC Point-of-Care Infectious Disease Diagnostics/Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 105. Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue (USD Million) by Players (2015-2020)
Table 106. Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue Share by Players (2015-2020)
Table 107. Key Players Point-of-Care Infectious Disease Diagnostics/Testing Revenue (USD Million) in United States (2015-2020)
Table 108. Key Players Point-of-Care Infectious Disease Diagnostics/Testing Revenue Share in United States (2015-2020)
Table 109. North America Point-of-Care Infectious Disease Diagnostics/Testing Revenue (USD Million) by Countries (2015-2020)
Table 110. North America Point-of-Care Infectious Disease Diagnostics/Testing Revenue Market Share by Countries (2015-2020)
Table 111. North America Point-of-Care Infectious Disease Diagnostics/Testing Revenue (USD Million) by Countries (2020-2026)
Table 112. North America Point-of-Care Infectious Disease Diagnostics/Testing Revenue Market Share by Countries (2020-2026)
Table 113. Europe Point-of-Care Infectious Disease Diagnostics/Testing Revenue (USD Million) by Countries (2015-2020)
Table 114. Europe Point-of-Care Infectious Disease Diagnostics/Testing Revenue Market Share by Countries (2015-2020)
Table 115. Europe Point-of-Care Infectious Disease Diagnostics/Testing Revenue (USD Million) by Countries (2020-2026)
Table 116. Europe Point-of-Care Infectious Disease Diagnostics/Testing Revenue Market Share by Countries (2020-2026)
Table 117. Asia-Pacific Point-of-Care Infectious Disease Diagnostics/Testing Revenue (USD Million) by Countries (2015-2020)
Table 118. Asia-Pacific Point-of-Care Infectious Disease Diagnostics/Testing Revenue Market Share by Countries (2015-2020)
Table 119. Asia-Pacific Point-of-Care Infectious Disease Diagnostics/Testing Revenue (USD Million) by Countries (2020-2026)
Table 120. Asia-Pacific Point-of-Care Infectious Disease Diagnostics/Testing Revenue Market Share by Countries (2020-2026)
Table 121. South America Point-of-Care Infectious Disease Diagnostics/Testing Revenue (USD Million) by Countries (2015-2020)
Table 122. South America Point-of-Care Infectious Disease Diagnostics/Testing Revenue Market Share by Countries (2015-2020)
Table 123. South America Point-of-Care Infectious Disease Diagnostics/Testing Revenue (USD Million) by Countries (2020-2026)
Table 124. South America Point-of-Care Infectious Disease Diagnostics/Testing Revenue Market Share by Countries (2020-2026)
Table 125. Middle East & Africa Point-of-Care Infectious Disease Diagnostics/Testing Revenue (USD Million) by Countries (2015-2020)
Table 126. Middle East & Africa Point-of-Care Infectious Disease Diagnostics/Testing Revenue Market Share by Countries (2015-2020)
Table 127. Middle East & Africa Point-of-Care Infectious Disease Diagnostics/Testing Revenue (USD Million) by Countries (2020-2026)
Table 128. Middle East & Africa Point-of-Care Infectious Disease Diagnostics/Testing Revenue Market Share by Countries (2020-2026)
Table 129. Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue (USD Million) by Type (2015-2020)
Table 130. Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue Share by Type (2015-2020)
Table 131. Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue Forecast by Type (2020-2025)
Table 132. Global Point-of-Care Infectious Disease Diagnostics/Testing Market Share Forecast by Type (2020-2025)
Table 133. United States Point-of-Care Infectious Disease Diagnostics/Testing Revenue (USD Million) by Type (2015-2020)
Table 134. United States Point-of-Care Infectious Disease Diagnostics/Testing Revenue Share by Type (2015-2020)
Table 135. United States Point-of-Care Infectious Disease Diagnostics/Testing Revenue Forecast by Type (2020-2025)
Table 136. United States Point-of-Care Infectious Disease Diagnostics/Testing Market Share Forecast by Type (2020-2025)
Table 137. Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue (USD Million) by Application (2015-2020)
Table 138. Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue Share by Application (2015-2020)
Table 139. Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue Forecast by Application (2020-2025)
Table 140. Global Point-of-Care Infectious Disease Diagnostics/Testing Market Share Forecast by Application (2020-2025)
Table 141. United States Point-of-Care Infectious Disease Diagnostics/Testing Revenue (USD Million) by Application (2015-2020)
Table 142. United States Point-of-Care Infectious Disease Diagnostics/Testing Revenue Share by Application (2015-2020)
Table 143. United States Point-of-Care Infectious Disease Diagnostics/Testing Revenue Forecast by Application (2020-2025)
Table 144. United States Point-of-Care Infectious Disease Diagnostics/Testing Market Share Forecast by Application (2020-2025)

List of Figures

Figure 1. Point-of-Care Infectious Disease Diagnostics/Testing Picture
Figure 2. Global Point-of-Care Infectious Disease Diagnostics/Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 3. Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue Market Share by Type in 2019
Figure 4. HIV POC Picture
Figure 5. Clostridium difficile POC Picture
Figure 6. HBV POC Picture
Figure 7. Pneumonia or Streptococcus associated infections Picture
Figure 8. Respiratory syncytial virus (RSV) POC Picture
Figure 9. HPV POC Picture
Figure 10. Influenza/Flu POC Picture
Figure 11. Other Infectious Disease POC Picture
Figure 12. Point-of-Care Infectious Disease Diagnostics/Testing Revenue Market Share by Application in 2019
Figure 13. Hospitals Picture
Figure 14. Clinics Picture
Figure 15. Home Picture
Figure 16. Assisted Living Healthcare Facilities Picture
Figure 17. Laboratories Picture
Figure 18. Others Picture
Figure 19. Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2025) (USD Million)
Figure 20. Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size Share by Regions (2015-2025)
Figure 21. Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size Share by Regions in 2019
Figure 22. Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue Market Share by Regions (2020-2025)
Figure 23. North America Point-of-Care Infectious Disease Diagnostics/Testing Revenue (USD Million) and Growth Rate (2015-2025)
Figure 24. Europe Point-of-Care Infectious Disease Diagnostics/Testing Revenue (USD Million) and Growth Rate (2015-2025)
Figure 25. Asia-Pacific Point-of-Care Infectious Disease Diagnostics/Testing Revenue (USD Million) and Growth Rate (2015-2025)
Figure 26. South America Point-of-Care Infectious Disease Diagnostics/Testing Revenue (USD Million) and Growth Rate (2015-2025)
Figure 27. Middle East & Africa Point-of-Care Infectious Disease Diagnostics/Testing Revenue (USD Million) and Growth Rate (2015-2025)
Figure 28. Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue Share by Players in 2019
Figure 29. Global Top 5 Players Point-of-Care Infectious Disease Diagnostics/Testing Revenue Market Share in 2019
Figure 30. Top 10 Players Point-of-Care Infectious Disease Diagnostics/Testing Revenue Market Share in Global Market in 2019
Figure 31. Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size (USD Million) by Type (2015-2025)
Figure 32. Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size Share by Application (2015-2025)
Figure 33. North America Point-of-Care Infectious Disease Diagnostics/Testing Market Size Share by Countries (2015-2025)
Figure 34. North America Point-of-Care Infectious Disease Diagnostics/Testing Market Size Share by Countries in 2019
Figure 35. United States Point-of-Care Infectious Disease Diagnostics/Testing Market Size (USD Million) and Forecast (2015-2025)
Figure 36. Canada Point-of-Care Infectious Disease Diagnostics/Testing Market Size (USD Million) and Forecast
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs